Please tell us about Puma Biotechnology. Mr. Auerbach: I’d be more than happy to. Puma is a biotech company that is dedicated to the development and commercialization of drugs for the treatment of ...

Today it was announced that pharmaceuticals are not exempt from Trump’s tariffs. How does this apply to medical devices? Are most devices manufactured offshore? Mr. Wittes: It’s company by company, ...

Vlad Vitoc, M.D., is Chairman of Board, Chief Executive Officer, and President of MAIA Biotechnology Inc. Dr. Vitoc has a broad array of experience across commercial strategic analysis and ...

Let’s start with a look at your coverage, and how it might have changed since we spoke in 2023. Mr. Lichtman: Sure. I cover a large group of medical device companies from micro cap to mega cap. I ...

How is your coverage weathering the tariff storm? Dr. Brozak: Our life sciences dedicated franchise, WBB Securities, is the busiest we’ve ever been in the history of the firm, and the life sciences ...

Please give us a brief overview of NeurAxis and its services. Mr. Carrico: Sure. NeurAxis is an early growth stage med-tech company, focused on treating disorders of the gut-brain interaction in the ...

We’ve spoken before, but just for readers who may not be familiar, let’s start with a refresher on the company, its mission, and some milestones. Mr. Do: BioVie has two assets that we are currently ...

Ilan Sobel has been the CEO of BioHarvest Sciences Inc. since July 2020. He brought the company’s first product, VINIA, to North America, building a direct-to-consumer machine that is now ...

Hartaj Singh is a Founding Partner of Tecumseh Partners, advising biotech companies on valuation, strategy, and investor engagement. He also writes The Biotech Capital Compass, a newsletter ...